STOCK TITAN
  1. Home
  2. Sec-filings
  3. IGC
  4. [EFFECT] IGC Pharma, Inc. SEC Filing

[EFFECT] IGC Pharma, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: December 5, 2025 4:00 P.M.
Form: S-3
CIK: 0001326205
Company Name: IGC Pharma, Inc.
File Number: 333-291567

Source: View Original Filing on SEC EDGAR

Stock IGC logo
IGC Pharma Inc

NYSE:IGC

IGC Rankings

#5806 Ranked by Market Cap
N/A Ranked by Dividends
#126 Top Gainer

IGC Latest News

Dec 19, 2025
IGC Pharma Secures New U.S. Patent as Pharmaceutical Cannabinoids Gain Regulatory Momentum
Dec 15, 2025
IGC Pharma Positions as a Singular Beneficiary of Emerging Federal Momentum Toward Schedule III Cannabinoid Medicines
Dec 10, 2025
IGC Pharma Announces Coverage Report by Ascendiant Capital Markets about the "Reports Q2 results. We believe more positive clinical data and progress in 2025/26 to be strong catalysts for stock. Raising P/T to $4.75."
Dec 9, 2025
IGC Pharma Reports 65% Patient Enrollment Milestone in Phase 2 CALMA Alzheimer's Agitation Trial
Dec 2, 2025
IGC Pharma Announces Publication of Landmark Caregiver Book on Alzheimer's Disease

IGC Latest SEC Filings

Dec 15, 2025
[8-K] IGC Pharma, Inc. Reports Material Event
Dec 3, 2025
[S-3/A] IGC Pharma, Inc. Amended Shelf Registration Statement
Nov 14, 2025
[S-3] IGC Pharma, Inc. Shelf Registration Statement
Nov 14, 2025
[10-Q] IGC Pharma, Inc. Quarterly Earnings Report
Nov 14, 2025
[8-K] IGC Pharma, Inc. Reports Material Event

IGC Stock Data

30.51M
85.33M
8.45%
18.55%
1%
Biotechnology
Pharmaceutical Preparations
Link
United States
POTOMAC